Crohn’s perianal fistulas (CPF) are a severe and disabling complication of Crohn’s disease (1) that can severely impact patient quality of life (QoL)(2). Despite this burden, few studies have assessed their impact from the patient perspective (3,4).
To help address this, The European Federation of Crohn’s and Ulcerative Colitis Associations (EFCCA), in collaboration with Takeda, commissioned and conducted a survey to understand not just the health-related impact, but the overall real-world impact of CPF on QoL.(3)
Takeda provided editorial support in the development and distribution of the survey and analysis of data, and funded medical writing of the publication of results.
This video is intended for an international audience (ex-US).
References:
1. Marzo M, Felice C, Pugliese D, et al. Management of perianal fistulas in Crohn’s disease: An up-to-date review. World J Gastroenterol. 2015; 21(5): 1394-1395.
2. Panés J, García-Olmo D, Van Assche G, Colombel JF, et al. ADMIRE CD Study Group Collaborators. Expanded allogeneic adipose-derived mesenchymal stem cells (Cx601) for complex perianal fistulas in Crohn's disease: a phase 3 randomised, double-blind controlled trial. Lancet. 2016;24;388(10051):1281-90.
3. Spinelli A, Yanai H, Lonnfors S, et al. The impact of perianal fistula in Crohn’s disease on quality of life: results of a patient survey conducted in Europe. Presented virtually at ECCO, July 2021.
4. Adegbola S, Dibley L, Sahnan K, et al. Burden of disease and adaptation to life in patients with Crohn’s perianal fistula: a qualitative exploration. Health Qual Life Outcomes. 2020; 18: 370.
C-ANPROM/INT/ALOFI/0075
Video date of preparation: November 2022
The survey was commissioned and conducted by EFCCA. Takeda provided editorial support in the development and distribution of the survey, analysis of data, and funded medical writing of the publication of results.
This video was produced and funded by Takeda. The information provided is not intended to make a diagnosis or to take the place of talking to a healthcare professional. Please consult your healthcare provider for medical advice.
The entire contents of this educational video is subject to copyright protection. The content may otherwise not be copied or used in any way without the prior written consent of Takeda. This video and all of its Contents, including but not limited to, all text and images (herein referred to as "Contents") are owned by Takeda, its affiliates and/or partners. No license to or right in any trademarks, patents, designs, trade secrets, technologies, products, process and other proprietary rights of Takeda, its affiliates and/or partners is granted to or conferred upon you.
Video job code: C-ANPROM/INT/ALOFI/0131
November 2022
Copyright (C) 2022 Takeda Pharmaceutical Company Limited. All rights reserved.
TAKEDA and the TAKEDA Logo are registered trademarks of Takeda Pharmaceutical Company Limited.
All other trademarks are the property of their respective owners.
